DECIPHERA PHARMACEUTICALS INC revenue breakdown overview

DECIPHERA PHARMACEUTICALS INC revenue for the last year amounted to 148.00 M EUR, the most of which — 144.12 M EUR — came from its highest performing source at the moment, Switch Control Kinase Inhibitor Platform, the year earlier bringing 117.27 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought DECIPHERA PHARMACEUTICALS INC 110.12 M EUR, and the year before that — 90.83 M EUR.